Aigh Capital Management LLC Cognition Therapeutics Inc Transaction History

Aigh Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$1.66 - $2.62 $2.65 Million - $4.18 Million	-1,596,507 Reduced 84.15%	300,766 $499,000
Q1 2024 May 14, 2024	SELL	$1.78 - $2.53 $252,012 - $358,197	-141,580 Reduced 6.94%	1,897,273 $3.45 Million
Q2 2023 Aug 14, 2023	BUY	$1.56 - $3.38 $1,560 - $3,380	1,000 Added 0.05%	2,038,853 $3.73 Million
Q4 2022 Feb 14, 2023	BUY	$1.17 - $3.51 $1.45 Million - $4.35 Million	1,239,518 Added 155.26%	2,037,853 $4.28 Million
Q3 2022 Nov 10, 2022	SELL	$1.63 - $3.6 $183,301 - $404,838	-112,455 Reduced 12.35%	798,335 $1.52 Million
Q2 2022 Aug 12, 2022	BUY	$1.5 - $3.45 $1.37 Million - $3.14 Million	910,790 New	910,790 $2.38 Million
Q1 2022 May 12, 2022	SELL	$2.41 - $6.9 $61,445 - $175,922	-25,496 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.1 - $12.98 $130,029 - $330,938	25,496 New	25,496 $161,000

6.58M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $13.2M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.